NCT04929015 2024-03-21
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Rutgers, The State University of New Jersey
Phase NA Unknown
Clinical Trials
25 trialsNCT06236594 2024-02-01
Endo-mmfi
Beijing 302 Hospital
Unknown
NCT05646043 2024-01-18
PREHAB - Improving Condition Before Surgery
University Hospital Ostrava
Phase NA Unknown
NCT05262335 2023-11-28
ALTER-G-001
Ruijin Hospital
Phase 2 Unknown
NCT06085365 2023-10-16
Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors
China Medical University, China
Phase 3 Unknown
NCT06054685 2023-10-10
Association Between Body Composition and Digestive System Cancer Survival
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05420558 2023-07-17
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
Zhongnan Hospital
Unknown
NCT04962958 2023-06-22
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT05913661 2023-06-22
Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT05673434 2023-01-06
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System
Changhai Hospital
Phase NA Unknown
NCT05238584 2022-05-20
TOPO
University of Debrecen
Phase NA Unknown
NCT04133324 2022-04-06
C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer
Moroccan Society of Surgery
Unknown
NCT04960943 2021-07-14
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors
Fudan University
Phase 2 Unknown
NCT04500990 2020-08-06
MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Prospective Observational Study
Peking University
Unknown
NCT03889626 2019-03-26
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
Fudan University
Phase 3 Unknown
NCT03271255 2019-01-23
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Phase 2 Unknown
NCT02005965 2018-09-18
MERCURY II
Royal Marsden NHS Foundation Trust
Unknown
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT01995942 2018-09-14
MARVEL
Royal Marsden NHS Foundation Trust
Unknown
NCT03488446 2018-04-05
Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701)
Nanfang Hospital, Southern Medical University
Unknown
NCT03303495 2017-10-06
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sun Yat-sen University
Phase 3 Unknown
NCT02530398 2017-08-30
A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites
Dongfang Hospital Beijing University of Chinese Medicine
Phase 1 Unknown
NCT02208804 2016-11-09
SIM
UMC Utrecht
Phase 2/3 Unknown
NCT01556815 2012-04-25
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01549418 2012-03-09
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4 Unknown